Skip to content

Prevention of cancers using eCROPS-CA (electronic supports and supervision, Counseling behavior prevention, Recipe for objective behaviors, Operational toolkit, Performance-based incentives for doctors, and Screening and assessment)

eCROPS-CA: a systematic approach toward effective and sustainable cancer prevention in rural China

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN33269053
Enrollment
4320
Registered
2014-05-15
Start date
2014-05-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nine common cancers (trachea/bronchus/lung cancer, stomach cancer, colon/rectum/anus cancer, liver cancer, esophagus cancer, breast cancer, pancreas cancer, lymphoma cancer, and bladder cancer) Cancer

Interventions

The study recruits 36 administrative villages from nine counties in Anhui province, China and assigns them into equal intervention and delayed intervention arms. The intervention arm receives baseline

Sponsors

Natural Science Foundation of China (China)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Men and women who: 1. Are over 35 years old 2. Llive in the selected villages for over 6 months per year 3. Meet rapid risk assessment score (=70) and detailed risk assessment score (=80) threshold

Exclusion criteria

Exclusion criteria: Villagers who have already diagnosed with cancer and mental illness or serious illness or disability are excluded.

Design outcomes

Primary

MeasureTime frame
Diagnosis of nine common cancers surveyed every 6 months after project initiation.

Secondary

MeasureTime frame
1. Cancer-related knowledge, attitudes and practices 2. Cancer-related biophysical indicators, e.g., hypertension, gastritis, pre-diabetes/diabetes 3. Intervention compliance Secondary outcome measure(s) will be measured using structured questionnaires (for objective behaviors and service use), scales (for body weight and height), sphygmomanometer (for blood pressure) and tests (for blood glucose and other easy biological indicators) at baseline and every 6 months after baseline for 5 years.

Countries

China

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 17, 2026